The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.

Li L, Zhang H, Xie Y, Su N, Su S, Zhang X, Cen W

Open source

DOI
10.1155/2022/1475871
Published
2022
Container
Computational and mathematical methods in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1475871,
  title = {The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.},
  author = {Li L and Zhang H and Xie Y and Su N and Su S and Zhang X and Cen W},
  year = {2022},
  journal = {Computational and mathematical methods in medicine},
  doi = {10.1155/2022/1475871},
  url = {https://doi.org/10.1155/2022/1475871}
}

RIS

TY  - JOUR
TI  - The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.
AU  - Li L
AU  - Zhang H
AU  - Xie Y
AU  - Su N
AU  - Su S
AU  - Zhang X
AU  - Cen W
PY  - 2022
JO  - Computational and mathematical methods in medicine
DO  - 10.1155/2022/1475871
UR  - https://doi.org/10.1155/2022/1475871
ER  - 

APA

L, L., H, Z., Y, X., N, S., S, S., X, Z., & W, C. (2022). The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.. Computational and mathematical methods in medicine. https://doi.org/10.1155/2022/1475871

Source records